Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
Luye Pharma Group, an international pharmaceutical has selected LifeSphere Signal and Risk Management as its next-generation signal detection tool.
ArisGlobal announced the release of LifeSphere CTMS , a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes.
Two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliates
ArisGlobal is thrilled to announce their participation at the World Drug Safety Congress Americas, September 01 – 02, 2020. Along with a large drug manufacturer, they will be co-presenting a session titled “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology”.
ArisGlobal, is thrilled to be a Corporate Support Sponsor and to attend the SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando in Orlando, Florida from February 18 – 21, 2020, presented by the Cambridge Healthtech Institute.
ArisGlobal to Present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform” on Tuesday, February 11, 2020, at DIA Regulatory Submissions, Information and Document Management Forum (RSIDM).
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.
ArisGlobal has expanded its partnership with Soterius, Inc., a global leader in providing drug safety and medical outsourcing services and solutions adding LifeSphere® MultiVigilance and LifeSphere® Medical Information to their service-oriented technology stack.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved